Advanced Medical Solutions Group plc

LSE AMS.L

Advanced Medical Solutions Group plc Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -25.78 M

Advanced Medical Solutions Group plc Net Cash Used For Investing Activities is USD -25.78 M for the year ending December 31, 2023, a -68.00% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Advanced Medical Solutions Group plc Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -15.35 M, a -76.93% change year over year.
  • Advanced Medical Solutions Group plc Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -8.67 M, a 76.52% change year over year.
  • Advanced Medical Solutions Group plc Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -36.94 M, a 7.06% change year over year.
  • Advanced Medical Solutions Group plc Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -39.74 M, a -625.04% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
LSE: AMS.L

Advanced Medical Solutions Group plc

CEO Mr. Andrew Christopher Meredith BSc (Hons)
IPO Date Dec. 16, 1994
Location United Kingdom
Headquarters Premier Park
Employees 1,500
Sector Health Care
Industries
Description

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.

Similar companies

RWS.L

RWS Holdings plc

USD 2.14

0.55%

APH.L

Alliance Pharma plc

USD 0.75

-0.07%

GBG.L

GB Group plc

USD 3.98

-0.52%

CVSG.L

CVS Group plc

USD 9.99

-0.88%

StockViz Staff

January 15, 2025

Any question? Send us an email